NeuroSense Therapeutics Ltd. Warrant (NASDAQ: NRSNW) last traded at $0.0355, up 0.00% on the session. The quote above updates while this page is open; the figures below are drawn from NeuroSense Therapeutics Ltd. Warrant’s own filings and are restated only when a new one is published.
NeuroSense Therapeutics Ltd. Warrant trades on NASDAQ under the ticker NRSNW. Its market capitalisation is $1.16 million.
Valuation measures for NeuroSense Therapeutics Ltd. Warrant, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.16M |
|---|---|
| Enterprise value | $3.58M |
Trailing-twelve-month figures tagged in NeuroSense Therapeutics Ltd. Warrant's XBRL filings with the SEC.
| Net income (TTM) | -$11.13M |
|---|---|
| EPS (TTM) | -$0.440 |
| Cash |
|---|
| $166.0K |
Range and volume for NRSNW over the past 52 weeks.
| 52-week high | $0.0396 |
|---|---|
| 52-week low | $0.0144 |
| Volume | 7 |
| Average volume | 7 |
| Previous close | $0.0355 |
Invest a chosen dollar amount in NeuroSense Therapeutics Ltd. Warrant with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell NRSNW.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.